PharmaPoint Dyslipidemia Global Drug Forecast and Market Analysis to 2025SummaryGlobalData estimates sales of dyslipidemia therapeutics to be approximately $11.2B across the 7MM in 2015 encompassing the US 5EU and Japan. The dyslipidemia market will grow ...
↧